Entheon Biomedical Corp.: Entheon Biomedical Subsidiary, HaluGen Life Sciences, Announces Agreement with Psychedelics Today
Expanding brand awareness and access to HaluGen's Psychedelics Genetic Test Kit Vancouver, British Columbia--(Newsfile Corp. - January 18, 2022) - Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE:
Source: finanznachrichten.de